Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral Sclerosis - 15/12/17
, Xiao Lin a, ⁎ , Yanlong Hong a, Yi Feng bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 11 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Purpose |
Amyotrophic lateral sclerosis (ALS) is a chronic, fatal neurodegenerative disease which leads to progressive muscle atrophy and paralysis. In order to summarize the characteristics of Traditional Chinese Medicine compounds and their preparations in the prevention and treatment of ALS through analyzing the mechanism, action site, and symptoms according to effective clinical research.
Methods |
We searched ALS, motor neuron disease, chemical drugs, herbal medicine, Chinese medicine, Traditional Chinese Medicine (TCM), and various combinations of these terms in databases including the PudMed, Springer, Ovid, Google, China National Knowledge Infrastructure, and Wanfang databases.
Result |
It was found that the chemical drugs almost had not sufficient evidence to show their effectiveness in the treatment of ALS, except RILUZOLE. According to the characteristics of clinical symptoms of ALS, Chinese medicine practitioners believe that this disease belongs to the category of “atrophic disease”. In clinical research, many Chinese herbal formulas had good clinical efficacies in the treatment of ALS with multiple targets, multiple links, and few side effects. And four kinds of dialectical treatment had been developed based on Clinical data analysis and the use of dialectical therapy: Benefiting the kidney; Declaring the lungs; Enhancing the Qi; and Dredging the meridian.
Conclusion |
In this review, we provide an overview of chemical drugs and Traditional Chinese Medicine compound and its preparations in therapy of ALS as well as how they may contribute to the ALS pathogenesis, thereby offering some clues for further studies.
Le texte complet de cet article est disponible en PDF.Abbreviations : ALS, Bcl, COX-2, DHYZ, DPPH, FALS, FasL, FDA, IFN, iNOS, JWL, JWSJZ, MDA, NFATC, PEG2, RAM, ROS, SALS, SJZT, SOD, TCM, TNF-α, TNFR1
Keywords : Amyotrophic lateral sclerosis, Traditional Chinese Medicine, Atrophic disease, Inflammatory reaction, Protein clear, Oxidative stress
Plan
Vol 96
P. 854-864 - décembre 2017 Retour au numéro
Article précédent
- The role of pazopanib on tumour angiogenesis and in the management of cancers: A review
- Dinesh Kumar Chellappan, Jestin Chellian, Zhao Yin Ng, Yan Jinn Sim, Chiu Wei Theng, Joyce Ling, Mei Wong, Jia Hui Foo, Goh Jun Yang, Li Yu Hang, Saranyah Nathan, Yogendra Singh, Gaurav Gupta
- Overview of Ganoderma sinense polysaccharide–an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China
- Yifei Jiang, Yajing Chang, Yong Liu, Meng Zhang, Heng Luo, Cui Hao, Pengjiao Zeng, Yue Sun, Hua Wang, Lijuan Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?